Motor Tics Guide for Parents Adults and Caregivers

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Motor tics are repeated movements that can involve the eyes, face, head, neck, shoulders, arms, hands, torso or legs. You may see eye blinking, facial movements, shoulder shrugging, head jerking, touching, tapping or repeated body movements that feel hard to stop. Motor tics can be simple and brief, or complex and patterned. They may appear alone, as part of persistent motor tic disorder or alongside vocal tics in Tourette syndrome. The Centers for Disease Control and Prevention (CDC) describes tics as sudden twitches, movements or sounds that people do repeatedly, with motor tics involving body movement.

Common movement examples

Motor tics can look different from person to person. Some are easy to miss. Others are visible enough to affect school, work, driving, sports or social settings.

Common motor tic examples include the following.

  • Eye blinking
  • Eye rolling
  • Nose twitching
  • Facial grimacing
  • Mouth movements
  • Jaw movements
  • Head jerking
  • Neck stretching
  • Shoulder shrugging
  • Arm jerking
  • Finger movements
  • Tapping
  • Touching objects
  • Bending
  • Twisting
  • Hopping

Early motor tics often appear in the head and neck area. CDC says Tourette syndrome symptoms often begin between ages 5 and 10, and the first symptoms are often motor tics in the head and neck.

A motor tic may look like a habit, but the inner experience can be different. You may feel pressure, tension or an urge before the movement. The tic may give brief relief, then return later. A child may not have the words to explain that feeling. They may simply say they “have to” move.

Simple movement tics

Simple motor tics are brief movements that use one muscle group or a small number of muscles. They may happen quickly and repeatedly.

Simple motor tics can include eye blinking, nose twitching, shoulder shrugging, facial movements, head jerks or mouth movements. These tics are often the first symptoms families notice.

A simple tic can still cause problems. Repeated eye blinking can irritate the eyes or interrupt reading. Shoulder shrugging can cause soreness. Head or neck jerks can create pain. Small movements can also draw attention in classrooms, meetings or public spaces.

Simple tics may come and go. A child may blink often for several weeks, then blink less and begin a different movement later. This shifting pattern is common in tic disorders. It does not mean the symptom was fake.

Complex movement tics

Complex motor tics involve a longer movement or a more coordinated sequence. They may look planned because they can resemble ordinary actions.

Complex motor tics can include touching objects, repeating a gesture, bending, hopping, twisting, stepping in a certain pattern or making several movements in a row. A person may tap a surface, touch clothing, stretch the neck or move the body in a repeated way.

These tics can be misunderstood. A student who touches a desk repeatedly may be seen as distracting others. An adult who repeats a gesture may worry about being judged in public. A complex motor tic can look intentional even when it is driven by an urge that feels hard to resist.

Complex motor tics can also overlap with compulsive behaviors. A tic is often linked to a body urge or physical sensation. A compulsion is often linked to fear, doubt or a need to reduce anxiety. Some people have both tics and obsessive compulsive symptoms, so a clinician may need to review the full pattern.

Pain, injury and disruption

Motor tics can affect the body when they are repeated often or performed forcefully. Pain is a valid reason to ask for clinical support.

Pain may show up in the neck, jaw, shoulders, back, eyes, hands or legs. Repeated head jerks can strain the neck. Jaw movements can cause soreness. Arm or hand tics can affect writing, typing, eating or tool use. Eye tics can make reading harder.

Motor tics can also create safety concerns. Tics that affect vision, head control, hands or legs may affect driving, sports, cooking, lab work, shop class or work around tools. If a tic creates a safety risk, discuss it with a qualified healthcare professional.

CDC states that many people with Tourette syndrome do not need treatment if tics do not interfere with life, while behavioral treatment and medication may help when tics cause pain, injury, school issues, work issues, social strain or stress.

Tracking without pressure

Tracking motor tics can help before a care visit, but constant watching can increase stress. Keep notes brief and practical.

You can track the following.

  • Main motor tics you notice
  • Age or date when symptoms began
  • How often tics appear
  • Pain or injury
  • School, work or social effects
  • Sleep, illness or stress patterns
  • Related attention, anxiety or obsessive symptoms
  • Safety concerns

For a child, avoid pointing out every tic. Ask about pain, teasing and school difficulty instead. A weekly note is often enough unless symptoms are severe or changing quickly.

For a teen, ask before recording tics. A short video can help a clinician, but privacy should be respected. For an adult, focus on function. Note if tics affect meetings, typing, driving, sleep, pain or public settings.

Motor tics in children

Motor tics often begin in childhood. A child may first show blinking, facial movements, nose twitching or head movements. These signs may be mistaken for allergies, eye irritation, behavior problems or stress.

If your child has motor tics, start with calm support. Do not punish the movement. Do not ask the child to stop over and over. A child may suppress a tic briefly, but that effort can be tiring.

School support may help when tics affect learning or peer relationships. A child with hand tics may need typed work or extra time. A child with head or eye tics may need breaks from reading. A child with visible movements may need staff support if peers tease, copy or record the tics.

A care visit may be useful if tics last, change, cause pain, affect school or appear with vocal tics. CDC explains that Tourette syndrome can be diagnosed when a person has both motor and vocal tics and tic symptoms have lasted at least one year. Persistent motor tic disorder may be diagnosed when motor tics last at least one year without vocal tics.

Motor tics in adults

Adults with motor tics may have had symptoms since childhood. Some were diagnosed early. Others were told for years that the movements were habits, nerves or behavior issues.

Adult motor tics can affect work, driving, exercise, social settings, parenting and pain levels. A neck tic may affect long computer work. A hand tic may affect typing or tool use. A facial tic may make public facing work more stressful.

Work support can be simple. You may need brief breaks, seating choice, written follow up after meetings, ergonomic changes or task changes when safety is affected. You can choose how much to share. A short explanation may help in some settings.

Adults should also review related conditions. Attention problems, obsessive compulsive symptoms, anxiety, sleep issues and pain can shape daily life. Treatment may focus on tics and these related concerns.

How motor tics differ from habits

Motor tics can look like habits, but several features can help your clinician tell them apart. A tic is often sudden, repeated and linked to an urge. It may rise and fall over time. It may change form across months.

A habit may be more connected to boredom, routine or learned behavior. Some habits can be stopped more easily when noticed. Tics often feel harder to suppress, and holding them back can take effort.

You do not need to decide alone. A clinician can review age of onset, movement pattern, urge, duration, other tics, medication history and related symptoms.

Seek faster medical review if movements begin suddenly in adulthood, appear with confusion, fainting, weakness, severe headache, fever, loss of awareness or seizure like events.

Links to vocal tics and symptoms

Motor tics are one part of the tic symptom picture. If you also notice repeated sounds, read a vocal tics guide. Vocal tics can include sniffing, throat clearing, coughing, grunting, humming, syllables, words or phrases.

If you are trying to compare several symptom types, read a Tourette syndrome symptoms guide. That page should explain motor tics, vocal tics, simple tics, complex tics, premonitory urges and changes over time.

If symptoms have lasted less than one year, a tic disorder guide can help explain provisional tic disorder. If both motor and vocal tics have lasted at least one year and began before age 18, a Tourette syndrome guide can help you prepare for a diagnostic discussion.

Treatment and support options

Support depends on impact. Mild motor tics may need monitoring only. Painful, disruptive or unsafe motor tics may need treatment.

CBIT is a behavioral tic treatment that may help children and adults. CDC describes CBIT as an evidence based behavioral therapy for Tourette syndrome and chronic tic disorders. It includes habit reversal, education about tics and relaxation techniques.

Medication may be considered when tics are severe, painful or disruptive. Medication choices require a qualified healthcare professional because benefits, side effects and monitoring needs vary.

Support may also include school accommodations, workplace changes, pain care, physical therapy, anxiety treatment or care for ADHD or obsessive compulsive symptoms. The plan should fit your daily needs.

Research context

Tic research continues to study brain circuits, childhood development, genetics, behavioral care, medication safety and related conditions. This research can help clinicians identify which supports help which people.

Regulated psychedelic research has also helped scientists study brain networks, emotion processing and future therapeutic models. Psilocybin is not an established treatment for motor tics or Tourette syndrome. Any research discussion should stay evidence based and separate from personal medical decisions.

Rose Hill research note

As you review motor tics, symptom patterns and future research questions, we at Rose Hill Life Sciences approach this topic through science led education. Our work focuses on psychedelic research, production and study of Psilocybe cubensis, the intersection of science and therapeutic integration and our Massachusetts research work, while motor tic diagnosis and treatment decisions should remain with qualified healthcare professionals.

Conclusion

If you notice repeated movements, write down the main motor tics, when they began, how long they have lasted and how they affect daily life. Include pain, school issues, work limits, safety concerns and related symptoms.

If motor tics are mild and not disruptive, ask a clinician about monitoring. If tics cause pain, injury, distress, school problems or work problems, ask about a fuller evaluation and support options.

If vocal tics are also present, mention them during the visit. That detail can affect the diagnosis. A clear symptom record helps your care team decide which tic disorder pattern fits and which level of care may help.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.